Research and Markets: Metered Dose Inhalers to 2022

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/p65j22/metered_dose) has announced the addition of the "Metered Dose Inhalers to 2022" report to their offering.

Metered dose inhalers have been around for more than thirty years, and while the underlying technology is relatively straightforward and mature, device developers and their inhaled drug partners have been able to add improvements and/or new features that address MDI limitations and advance ease-of-use. Because of the underlying physiology of the human respiratory system, inhaled drug pharmacodynamics, and marked variations in the use of inhalers across patient populations, inhaler design presents unique challenges to device developers. Recent improvements in the control of the inspiry event have reduced the need for add-on devices designed to help regulate patient administration. Growth in upper airway therapeutics will help to push MDI unit demand to high single digits between now and the end of the decade.

What You Will Learn

- What inhalable drugs are supplied in MDIs, how are they marketed, what are the device specifics, and who markets them?

- What inhalable MDI products are in late stage development, who are the developers, and what indications are they targeting?

- What are the major factors driving metered dose inhaled drug/device demand?

- What is the size of the market today, who are the market share leaders, and what will the market share be in 2022?

- How important are drug developer-device manufacturer relationships and what are the key alliances in the industry?

- What are the essential design factors, material selection issues, technologies and market development issues MDI products?

- What are the significant economic, technology, and regulatory factors affecting the market for MDIs?

Key Topics Covered:

1. Executive Summary

2. Inhaled Drug Delivery Market Dynamics

3. Devices and Formulations

- Market Segments and Indications

- Competing Technologies

- Established Therapeutic Targets

- Demographics and Growth

- Market Drivers

- Risk Factors

4. MDI Technology Factors

- Device Strategies

- Device Characteristics

- Design Parameters

5. MDI Performance Factors

- Dose Delivery and Patient Training

- Breath actuation

- Doses and Dose Counters

- Dual (Combination) Drug MDIs

6. MDI Product Assessments and Analysis

- Branded Drug Inhalers

- Generic DPI Inhalers

- Combination Drug Inhalers

7. Therapeutic Market Analysis, Market Data and Forecasts

- Asthma

- Adult Asthma

- Pediatric Asthma

- COPD

8. Market Factors

- Clinical Trials

- Proprietary Technology

- Managed Care

9. Company Profiles

For more information visit http://www.researchandmarkets.com/research/p65j22/metered_dose

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Inhalers and Nebulisers

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Inhalers and Nebulisers